Uses, Dosage & Side Effects: Kadcyla Injection
Kadcyla Injection
| Generic name | trastuzumab emtansine (ado-trastuzumab emtansine) |
|---|---|
| Drug class | Antineoplastic Agent (HER2-targeted antibody-drug conjugate) |
| Forms | Single-use vial containing 100 mg sterile powder for intravenous infusion, Single-use vial containing 160 mg sterile powder for intravenous infusion |
Kadcyla is a cancer medicine made of two parts joined together: a monoclonal antibody called trastuzumab and a chemotherapy drug called DM1. It is given by IV infusion to treat HER2-positive breast cancer.
Read the full guideUses, dosage, side effects, precautions, and sources, written from the same verified facts.
General information, not medical advice
Your prescriber and the leaflet in your pack know your situation. This page does not.
- Follow your prescriber and the leaflet
- Don't start, stop, or change a dose on your own
- Doses and warnings differ by country and product
Took too much, or feel seriously unwell? Get urgent medical help now.
Facts checked by a personFull disclaimer
